GLP-1 and beta-cell preservation — looking for input

Wanted to share some data with the community since I know we're all about evidence here.

Background: I have been tracking everything meticulously since starting my GLP-1 12 months ago. Here's what I have found regarding glp-1 and beta-cell preservation looking for.

I'll post my numbers below and would love to see others share theirs too. The more data points we have, the better we can all make informed decisions.

Fair warning — this is a long post. TL;DR at the bottom for those who do not want the full breakdown.

To answer the question about GLP-1 and beta-cell preservation looking for input — in my experience this comes down to a few key factors.

I have been dealing with this for over a year now, and what I have found is that individual responses really do vary. That said, the general consensus on GLP-1 and beta-cell seems solid.

What specifically worked for me: getting baseline labs before making any changes. I would suggest steph_laguna try the same approach and reporting back.

Dr.SleepRoch said:

I have been dealing with this for over a year now, and what I have found is that individual response

Completely agree with Dr.SleepRoch. I would add that GLP-1 and beta-cell also has implications for long-term metabolic health that sometimes get overlooked in these discussions.

In my case, following a similar approach led to significant improvements compared to what I was doing before.

Subscribing to this thread. GLP-1 and beta-cell is exactly what I've been researching. 🙏

As a pharmacist, I want to add some clinical context to this discussion on GLP-1 and beta-cell preservation .

Building on what steph_laguna said — the evidence base here is robust. The key publications to reference are from the SELECT program[1].

Key clinical points:

1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
2. Side effect profile is predictable and usually manageable with standard protocols
3. Monitoring should include baseline labs and follow-up at 3-month intervals
4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.